Presentation, Management, and Outcomes of Patients With Giant Pheochromocytoma
Patients with giant PHEOs compared to referents were more symptomatic, had a higher degree of catecholamine excess, and had a higher rate of perioperative complications. Almost half of patients with giant PHEOs developed metastases, warranting close follow-up.
Authors
- Nasrin Nikravangolsefid (ORCID: https://orcid.org/0000-0003-1362-6769)
- Justin W. Maroun (ORCID: https://orcid.org/0000-0002-6797-1050)
- Trenton R. Foster (ORCID: https://orcid.org/0000-0003-0423-2370)
- Irina Bancos (ORCID: https://orcid.org/0000-0001-9332-2524)
- William F. Young (ORCID: https://orcid.org/0000-0001-5481-4884)
- Bahar Bahrani Fard (ORCID: https://orcid.org/0000-0003-2652-5481)
- Melanie L. Lyden (ORCID: https://orcid.org/0000-0002-9306-4016)
- Benzon M. Dy (ORCID: https://orcid.org/0000-0002-1943-0495)
- Ashton E Cross
- Travis J. McKenzie
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1210/clinem/dgae612
- Citations
- 1
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 0.57